Abstract
This review focuses on the recent developments and future trends dealing with its modifications, encompassing the different grades of polymethacrylates polymers based formulations. The last three decades of pioneering works explain it as a new functional material of high potential value in novel drug delivery. Polymethacrylates are synthetic cationic and anionic copolymers of dimethylaminoethyl methacrylates, methacrylic acid, and methacrylic acid esters in varying ratios, generating a new and modified patterned polymer due to their electrical characters and pH- dependent solubility. Based on current research and existing products, some new and futuristic approaches in this fascinating area have been thoroughly explored and discussed. These polymers are used as release retardant in different formulations like oral capsules and tablets, film-coating agents for protective purposes and provide sustained release formulations. This review also screens the current applications of these polymers in the development of microparticles, patches, nanoparticles, colon targeted formulations, ophthalmic, vaccine delivery, taste masking agent and its pivotal application in gene delivery systems. This work summarizes the achievements of past which can be extrapolated to characterize the possible array of polymeric interactions, exploiting their desirable properties for future studies.
Keywords: Applications, polymethacrylates, review
Current Drug Therapy
Title:Applicability and Approaches of (Meth) Acrylate Copolymers (Eudragits) in Novel Drug Delivery Systems
Volume: 7 Issue: 4
Author(s): Kumar Animesh, Moin Afrasim, Rami R. Bommareddy, Ahmed Ayaz, Ravi Shruthi and Hoskote G. Shivakumar
Affiliation:
Keywords: Applications, polymethacrylates, review
Abstract: This review focuses on the recent developments and future trends dealing with its modifications, encompassing the different grades of polymethacrylates polymers based formulations. The last three decades of pioneering works explain it as a new functional material of high potential value in novel drug delivery. Polymethacrylates are synthetic cationic and anionic copolymers of dimethylaminoethyl methacrylates, methacrylic acid, and methacrylic acid esters in varying ratios, generating a new and modified patterned polymer due to their electrical characters and pH- dependent solubility. Based on current research and existing products, some new and futuristic approaches in this fascinating area have been thoroughly explored and discussed. These polymers are used as release retardant in different formulations like oral capsules and tablets, film-coating agents for protective purposes and provide sustained release formulations. This review also screens the current applications of these polymers in the development of microparticles, patches, nanoparticles, colon targeted formulations, ophthalmic, vaccine delivery, taste masking agent and its pivotal application in gene delivery systems. This work summarizes the achievements of past which can be extrapolated to characterize the possible array of polymeric interactions, exploiting their desirable properties for future studies.
Export Options
About this article
Cite this article as:
Animesh Kumar, Afrasim Moin, R. Bommareddy Rami, Ayaz Ahmed, Shruthi Ravi and G. Shivakumar Hoskote, Applicability and Approaches of (Meth) Acrylate Copolymers (Eudragits) in Novel Drug Delivery Systems, Current Drug Therapy 2012; 7 (4) . https://dx.doi.org/10.2174/157488512804999082
DOI https://dx.doi.org/10.2174/157488512804999082 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of Salinomycin on Cancer Stem Cell in Human Lung Adenocarcinoma A549 Cells
Medicinal Chemistry Anti-carcinogenic Effect of Cathepsin K Inhibitor, Odanacatib with a Low Dose of Cisplatin Against Human Breast Carcinoma MCF-7 and MDA-MB231 Cells
Current Cancer Therapy Reviews Supplementation, Optimal Status, and Analytical Determination of Vitamin D: Where are we Standing in 2012?
Anti-Cancer Agents in Medicinal Chemistry HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors-Considerations for Successful Immunotherapy
Anti-Cancer Agents in Medicinal Chemistry ESDA: An Improved Approach to Accurately Identify Human snoRNAs for Precision Cancer Therapy
Current Bioinformatics Resveratrol-Mediated Reversal of Tumor Multi-Drug Resistance
Current Drug Metabolism Molecular Pathways and Related Target Therapies in Liver Carcinoma
Current Pharmaceutical Design Electroporation Advances in Large Animals
Current Gene Therapy Exploration of Chemical Space Based on 4-Anilinoquinazoline
Current Medicinal Chemistry Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer
Current Drug Targets Structure, Roles and Inhibitors of a Mitotic Protein Kinase Haspin
Current Medicinal Chemistry Development of Small-Molecule Inhibitors of Raf
Recent Patents on Anti-Infective Drug Discovery Human Platelets Express Authentic CB1 and CB2 Receptors
Current Neurovascular Research Progress of HDAC Inhibitor Panobinostat in the Treatment of Cancer
Current Drug Targets Genomic Instability and Carcinogenesis: An Update
Current Genomics Antiangiogenic Agents: Studies on Fumagillin and Curcumin Analogs
Current Pharmaceutical Design Peripheral Neuropathy Induced by Paclitaxel: Recent Insights and Future Perspectives
Current Neuropharmacology Molecular Targets and Targeted Therapies for Malignant Mesothelioma
Current Medicinal Chemistry A Review on Natural Sources Derived Protein Nanoparticles as Anticancer Agents
Current Topics in Medicinal Chemistry Prognostic Value and Clinicopathological Differences of Bmi1 in Gastric Cancer: A Meta-analysis
Anti-Cancer Agents in Medicinal Chemistry